Presence of Cardiomyopathy in DLBCL Drives Treatment Decisions
Physician's Weekly
JUNE 16, 2025
Oncology providers vary widely and diverge from guidelines in their preferred treatments of adults with diffuse large B-cell lymphoma (DLBCL) and pre-existing cardiomyopathy, according to the results of a nine-country survey demonstrate. “In 32% would routinely order a post-treatment echocardiogram.
52 
Let's personalize your content